SAMHD1 and metabolic dysfunction-associated steatotic liver disease: In vivo, hepatocyte-specific SAMHD1 overexpression increased liver steatosis, while hepatocyte-specific SAMHD1 knockout alleviated liver steatosis and injury in a GAN diet-induced MASLD model.